Health Education Articles | PlexusDx – Tagged "medicare"

Editorial illustration comparing Foundayo insurance pricing with cash-pay GLP-1 protocols — PlexusDx Precision Peptide Genetic Test, GLP-1 pathway genetics

Foundayo Cost With Insurance: What You'll Actually Pay in 2026

Foundayo costs $25/month with covered commercial insurance, $50/month on the Medicare GLP-1 Bridge, or $149-$289/mo self-pay through LillyDirect. Most commercial plans don't cover GLP-1s for weight loss in 2026. Compare cash-pay PlexusDx Weight Management Protocols — Microdose at $129/mo flat, Semaglutide Injection $189/mo, Tirzepatide Injection $289/mo — with no membership fee.

Best cash-pay GLP-1 for seniors on Medicare in 2026 — PlexusDx Microdose, Semaglutide, and Tirzepatide protocols compared

Best Cash-Pay GLP-1 for Seniors on Medicare (2026): Affordable Options That Work

Medicare Part D is statutorily prohibited from covering GLP-1s prescribed solely for weight loss, and manufacturer copay cards are off-limits to Medicare beneficiaries. This guide explains the Medicare GLP-1 Bridge launching July 2026, Part D backdoors for diabetes, CVD, and OSA, and the cash-pay options that work today — including PlexusDx Microdose GLP-1 Protocol at $129/mo flat and Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan.

Verify Approval for www.plexusdx.com

PlexusDx is LegitScript certified.

LegitScript is an independent group that reviews health companies. Tap the seal to check our status yourself.

Keep in Touch

Subscribe to our newsletter and stay up-to-date on new reports, tests, and health tips designed to help you live your healthiest life.

Important information about your prescription program.

PlexusDx is not a medical practice or pharmacy. Using this website does not create a doctor-patient relationship between you and PlexusDx.

Clinical services are provided by an independent network of U.S.-licensed clinicians through a state-licensed telehealth platform. Compounded medications are dispensed by state-licensed compounding pharmacies. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality.

If you would prefer a branded, FDA-approved prescription medication, your provider may write a prescription that you can fill at the pharmacy of your choice. PlexusDx does not sell or ship branded prescription medications.

Medication and clinical service fees are billed and collected by the practice-management platform that supports the prescribing clinicians. PlexusDx is paid separately for the data, referral, and customer-experience services that PlexusDx provides. PlexusDx is not the merchant of record for any prescription medication.

The GLP-1 & Peptide Pathways Genetic Test and any other genetic test or report sold by PlexusDx is intended to provide personalized educational information about your biology. It does not recommend, prescribe, or determine which medications a customer should use. Treatment decisions are made by your independent prescribing clinician based on your full medical history.

Product images on this site are illustrative and may not represent actual product packaging.

Individual results vary. Statements regarding outcomes are not guarantees and have not been evaluated by the FDA.

All content on this site is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Always seek the advice of a qualified clinician with any questions you may have about a medical condition or treatment.

Ozempic®, Wegovy®, Rybelsus®, Zepbound®, and Mounjaro® are registered trademarks of their respective owners and are not affiliated with PlexusDx.